After knockdown, we observed no difference in viability of cell spheroids between PFKFB3-silenced SAS and TW2.6 cells untreated or treated with 0.025–0.2 μM of PTX or 50 μM of CIS (Fig. 5A). This evidence concerns the gene PFKFB3 and in situ carcinoma.